Cargando…
Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
Antigen-based therapies (ABTs) fail to restore normoglycemia in newly diabetic NOD mice, perhaps because too few β-cells remain by the time that ABT-induced regulatory responses arise and spread. We hypothesized that combining a fast-acting anti-inflammatory agent with an ABT could limit pathogenic...
Autores principales: | Tian, Jide, Dang, Hoa, Nguyen, An Viet, Chen, Zheying, Kaufman, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141368/ https://www.ncbi.nlm.nih.gov/pubmed/25146474 http://dx.doi.org/10.2337/db13-1385 |
Ejemplares similares
-
Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted ß-Cells in Diabetic NOD Mice
por: Tian, Jide, et al.
Publicado: (2011) -
Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice
por: Suarez-Pinzon, Wilma L., et al.
Publicado: (2008) -
A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human β-Cell Replication and Survival as well as GABA's Ability to Inhibit Inflammatory T Cells
por: Tian, Jide, et al.
Publicado: (2019) -
Clinically applicable GABA receptor positive allosteric modulators promote ß-cell replication
por: Tian, Jide, et al.
Publicado: (2017) -
Dendritic cell–expanded, islet-specific CD4(+) CD25(+) CD62L(+) regulatory T cells restore normoglycemia in diabetic NOD mice
por: Tarbell, Kristin V., et al.
Publicado: (2007)